Profit after tax was down 74.9% in the company’s latest financial year, while HEPS went up 11%
Drug maker’s share price fell the most since March 2019, down 13.23% to R206
Business Day TV spoke to Aspen’s Group CEO, Stephen Saad
Business Day TV speaks to Adcock Ingram CEO Andy Hall
Lecanemab’s high cost and need for intensive monitoring for side effects ‘means it cannot be considered good value for the taxpayer’
Pharmaceutical manufacturer says increased demand for its winter products boosted turnover
Regulator and trustees to co-manage after the medical scheme runs into trouble with reserves
Bower joined the board as an independent nonexecutive director in 2015 and was appointed chairperson in January 2023
Zantac became the world’s best-selling medicine in 1988 and one of the first to top $1bn in annual sales
Novo Nordisk will provide ‘expertise in insulin production’ and Bio Farma will provide manufacturing facilities
Government comes to the rescue with some competition exemptions
Life says it has retained R1bn to provide for funding requirements of LMI as part of the Alliance Medical Group disposal
Business Day TV spoke to Stavros Nicolaou, senior executive for strategic trade at Aspen
Judge’s ruling a blow for British drugmaker
Coalition for Epidemic Preparedness Innovations and vaccine maker expand partnership
Business Day TV spoke to Life Healthcare's CEO Peter Wharton-Hood
Peter Wharton-Hood advocates for ‘constructive engagement’ and closer collaboration
Tirzepatide cleared for use, intensifying competition with Novo Nordisk in the biggest Asian market
Business Day TV speaks to Richard Friedland, CEO of Netcare
CEO Pascal Soriot laudes Singapore as a top global venue for investment